An Estimate of the Economic Impact of Treatment of NSCLC With Immunotherapy Relative to PD-L1 Expression in Brazil
dc.citation.issue | 10s | |
dc.citation.volume | 11 | |
dc.contributor.author | Aguiar Junior, Pedro Nazareth [UNIFESP] | |
dc.contributor.author | De Mello, Ramon | |
dc.contributor.author | Tadokoro, Hakaru [UNIFESP] | |
dc.contributor.author | Gutierres, Barbara | |
dc.contributor.author | Barreto, Carmelia [UNIFESP] | |
dc.contributor.author | Babiker, Hani | |
dc.contributor.author | Lopes, Gilberto | |
dc.coverage | New York | |
dc.date.accessioned | 2020-07-31T12:47:47Z | |
dc.date.available | 2020-07-31T12:47:47Z | |
dc.date.issued | 2016 | |
dc.description.affiliation | Univ Fed Sao Paulo, Clin Oncol, Sao Paulo, Brazil | |
dc.description.affiliation | Univ Algarve, Faro, Portugal | |
dc.description.affiliation | Univ Fed Sao Paulo, Sao Paulo, Brazil | |
dc.description.affiliation | Univ Paulista, Sao Paulo, Brazil | |
dc.description.affiliation | Honor Hlth, Scottsdale, AZ USA | |
dc.description.affiliation | Oncoclin Brasil, Sao Paulo, Brazil | |
dc.description.affiliationUnifesp | Clinical Oncology, Universidade Federal de São Paulo (UNIFESP), São Paulo/BRAZIL | |
dc.description.affiliationUnifesp | Universidade Federal de São Paulo (UNIFESP), São Paulo/BRAZIL | |
dc.description.provenance | Made available in DSpace on 2020-07-31T12:47:47Z (GMT). No. of bitstreams: 0 Previous issue date: 2016 | en |
dc.description.source | Web of Science | |
dc.format.extent | S246-S246 | |
dc.identifier | http://dx.doi.org/10.1016/j.jtho.2016.08.116 | |
dc.identifier.citation | Journal Of Thoracic Oncology. New York, v. 11, n. 10s, p. S246-S246, 2016. | |
dc.identifier.doi | 10.1016/j.jtho.2016.08.116 | |
dc.identifier.issn | 1556-0864 | |
dc.identifier.uri | https://repositorio.unifesp.br/handle/11600/57080 | |
dc.identifier.wos | WOS:000427345100109 | |
dc.language.iso | eng | |
dc.publisher | Elsevier Science Inc | |
dc.relation.ispartof | Journal Of Thoracic Oncology | |
dc.relation.ispartof | IASLC 7th Latin American Conference on Lung Cancer | |
dc.rights | Acesso aberto | |
dc.subject | immunotherapy | en |
dc.subject | Farmacoeconomy | en |
dc.subject | biomarker | en |
dc.subject | cost-effectiveness | en |
dc.title | An Estimate of the Economic Impact of Treatment of NSCLC With Immunotherapy Relative to PD-L1 Expression in Brazil | en |
dc.type | Trabalho apresentado em evento |